ImmunoGen, Inc. (IMGN) is at an implied volatility extreme high of 88.21% that is greater than 84.17% of past values prior to 4/7/2010 (Close Price 8.35). On prior close, 4/6/2010, the implied volatility was 69.87% and at the 54.10 percentile. Closing price was 8.15.
Today's News on ImmunoGen, Inc.
Today's News on ImmunoGen, Inc.
A Look at Immunogen Beyond the T-DM1 Setback
ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September
[Business Wire] - WALTHAM, Mass.----ImmunoGen, Inc. , a
biotechnology company that develops antibody-based targeted
anticancer products, today announced that Company management will
present at multiple investor conferences this month.
August's Biggest Biotech Losers
Stock Option Volatility Trading
A service of Trotter Trading Systems
Tuesday, Sep 7, 2010